Therapy and Vein Access Market. Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Intravenous (IV) Therapy and Vein Access Market" report has been added to Research ...

Intravenous antihypertensive agents for the ... The rapid recognition and initiation of therapy are key to minimizing end-organ damage in patients with hypertensive emergency.

Protara Therapeutics (TARA) announced that data from THRIVE-1, a prospective, observational study evaluating the prevalence of choline ...

The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...

A pair of clinical data sets gives Novartis confidence in a new formulation of the company’s gene therapy Zolgensma for the ...

The DRIPBaR Statesboro has launched a new mobile hydration service, bringing IV therapy treatments directly to homes, offices, and events within a 30-mile radius on select weekends.

Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).

LED light therapy, IV therapy, contrast therapy, cryotherapy, and naturopathic medicine, all services “designed to stack and complement one another making for a unique wellness experience.” ...